Status | Study |
Recruiting |
Study Name: Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma Condition: Intracranial Germinoma Date: 2016-05-23 Interventions: Drug: Carboplatin Drug: Etoposide |
Active, not recruiting |
Study Name: Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Condition: Childhood Central Nervous System Germ Cell Tumor Childhood Central Ner Date: 2012-05-18 Interventions: Procedure: therapeutic conventional surgery |
Active, not recruiting |
Study Name: Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Condition: Central Nervous System Tumor, Pediatric Chemotherapy-induced Nausea and Vomiting Date: 2011-04-29 Interventions: Procedure: Real Acupressure Band |
Completed |
Study Name: Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma Condition: Brain and Central Nervous System Tumors Lymphoma Lymphopro Date: 2011-01-07 Interventions: Drug: imetelstat sodium Other: laboratory |
Completed |
Study Name: PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors Condition: Brain and Central Nervous System Tumors Date: 2010-07-07 Interventions: Drug: VEGF inhibitor PTC299 This is a dose escalation study. Study participants will receive .6 or 1.2 m |
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-03-16 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Completed |
Study Name: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-02-25 Interventions: Drug: vorinostat Other Names: |
Completed |
Study Name: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Condition: Childhood Burkitt Lymphoma Childhood Central Nervous System Choriocarcinoma Date: 2009-10-10 Interventions: Drug: vorinostat Given orally |
Completed |
Study Name: Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment Condition: Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Embryonal Date: 2009-06-27 Interventions: Drug: pazopanib hydrochloride |
Recruiting |
Study Name: Collecting and Storing Tissue From Young Patients With Cancer Condition: Cancer Date: 2009-05-09 Interventions: Genetic: DNA analysis Genetic: reverse tra |